View ValuationTecan Group 将来の成長Future 基準チェック /46Tecan Group利益と収益がそれぞれ年間48%と4.8%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に8.7% 47.7%なると予測されています。主要情報48.0%収益成長率47.70%EPS成長率Life Sciences 収益成長20.5%収益成長率4.8%将来の株主資本利益率8.74%アナリストカバレッジGood最終更新日10 Jul 2026今後の成長に関する最新情報お知らせ • May 13Tecan Group AG Reaffirms Earnings Guidance for the Year 2026Tecan Group AG reaffirmed earnings guidance for the year 2026. The company reaffirms its 2026 guidance, as most recently communicated on March 16, 2026, with sales growth in the low single-digit percentage range in local currencies.すべての更新を表示Recent updatesBuy Or Sell Opportunity • Jun 05Now 23% undervaluedOver the last 90 days, the stock has risen 19% to €171. The fair value is estimated to be €222, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.5% over the last 3 years. Meanwhile, the company became loss making.お知らせ • May 13Tecan Group AG Reaffirms Earnings Guidance for the Year 2026Tecan Group AG reaffirmed earnings guidance for the year 2026. The company reaffirms its 2026 guidance, as most recently communicated on March 16, 2026, with sales growth in the low single-digit percentage range in local currencies.お知らせ • Apr 16Tecan Group Ag Announces Executive ChangesTecan Group AG in its AGM meeting held on April 15, 2026, announced that shareholders elected three new members of the Board of Directors: Nina Beikert, Gitte Pugholm Aabo and Guillaume Daniellot. Matthias Gillner, who has been a member of the Board of Directors since 2023 and its Vice-Chairman, was elected as the new Chairman. He will step down as Chair of the Audit Committee but will remain a member, alongside Guillaume Daniellot and Gitte Pugholm Aabo. With the addition of the newly elected members, the Board of Directors will once again comprise seven members, ensuring an optimal balance of expertise, skills, and experience for the future. Lukas Braunschweiler, Chairman and a member of the Board since 2018, did not stand for re-election.お知らせ • Mar 30The Tecan Group Announces the Appointment of Camila Japur as Chief Financial Officer, Effective on June 1, 2026The Tecan Group announced the appointment of Camila Japur as Chief Financial Officer, who will join the company on June 1, 2026. Camila currently serves as Group CFO of u-blox, where she has successfully led transformation initiatives, driving cost efficiency, strengthening financial processes, and enhancing capital market engagement. Prior to this, Camila spent 24 years at Ericsson, including seven years as CFO for the Enterprise Segment. Camila has an MBA from Fundação Getulio Vargas in São Paulo and a Bachelor's Degree in Economics from Universidade Mackenzie in São Paulo.お知らせ • Mar 25Tecan Group AG Announces Member of the Board of Directors Oliver Fetzer Will Not Stand for Re-ElectionTecan Group AG announced that Oliver Fetzer, a member of the Board since 2011, has decided not to stand for re-election at the AGM to be held on April 15, 2026.Reported Earnings • Mar 17Full year 2025 earnings released: CHF8.74 loss per share (vs CHF5.30 profit in FY 2024)Full year 2025 results: CHF8.74 loss per share (down from CHF5.30 profit in FY 2024). Revenue: CHF882.5m (down 5.5% from FY 2024). Net loss: CHF110.7m (down 264% from profit in FY 2024). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Life Sciences industry in Europe.お知らせ • Mar 16+ 1 more updateTecan Group AG Proposes Dividend for the Full Year 2025The Board of Directors of Tecan Group AG will propose an unchanged dividend of CHF 3.00 per share at the Annual General Meeting on April 15, 2026 for the full year 2025. Half of the dividend, i.e., CHF 1.50, will again be paid out from the available capital contribution reserve and is therefore not subject to withholding tax.Board Change • Mar 02Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Jan 28Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €173, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 18x in the Life Sciences industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €294 per share.Board Change • Jan 13Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Dec 19Tecan Group AG to Report First Half, 2026 Results on Aug 11, 2026Tecan Group AG announced that they will report first half, 2026 results on Aug 11, 2026お知らせ • Dec 05Tecan Group AG, Annual General Meeting, Apr 15, 2026Tecan Group AG, Annual General Meeting, Apr 15, 2026.お知らせ • Dec 04ecan Group AG Announces Chairman of the Board of Directors Lukas Braunschweiler Will Not Stand for Re-ElectionTecan Group AG announced that Lukas Braunschweiler, Chairman of the Board of Directors and a member of the Board since 2018, will not stand for re-election.お知らせ • Dec 02Tecan Group AG (SWX:TECN) acquired Wako Automation.Tecan Group AG (SWX:TECN) acquired Wako Automation on December 1, 2025. Tecan Group AG (SWX:TECN) completed the acquisition of Wako Automation on December 1, 2025.お知らせ • Nov 17+ 1 more updateTecan Group AG Announces Departure of Tania Micki as Member of the Management BoardTecan Group AG announced that Tania Micki, member of the Management Board since February 2020, will be leaving the company to pursue an external opportunity. She will continue in her role through May 2026 to ensure a smooth transition. Tecan will nominate her successor in due time, leveraging the company’s succession planning process.Board Change • Nov 05Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.業績と収益の成長予測WBAG:TECN - アナリストの将来予測と過去の財務データ ( )CHF Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20289879189146712/31/20279307474126812/31/20268845874131812/31/2025882-111103138N/A9/30/2025895-24118152N/A6/30/202590763134165N/A3/31/202592065126157N/A12/31/202493468118149N/A9/30/202496785105135N/A6/30/20241,00010193122N/A3/31/20241,037117109141N/A12/31/20231,074132126161N/A9/30/20231,088120114151N/A6/30/20231,102109101140N/A3/31/20231,12311597134N/A12/31/20221,14412192128N/A9/30/20221,11011391129N/A6/30/20221,07710589129N/A3/31/20221,012113110149N/A12/31/2021947122130170N/A9/30/2021911136163203N/A6/30/2021875150195237N/A3/31/2021803127181223N/A12/31/2020731104167208N/A9/30/202069194142177N/A6/30/202065184118146N/A3/31/20206447996122N/A12/31/2019637737599N/A9/30/201962770N/A95N/A6/30/201961667N/A90N/A3/31/201960569N/A92N/A12/31/201859471N/A93N/A9/30/201858270N/A99N/A6/30/201857069N/A106N/A3/31/201855967N/A103N/A12/31/201754966N/A99N/A9/30/201753662N/A93N/A6/30/201752357N/A86N/A3/31/201751556N/A102N/A12/31/201650655N/A119N/A9/30/201649155N/A124N/A6/30/201647655N/A129N/A3/31/201645856N/A114N/A12/31/201544057N/A99N/A9/30/201543452N/A83N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: TECNは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 2.3% ) よりも高い成長率であると考えられます。収益対市場: TECN今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。高成長収益: TECN今後 3 年以内に収益を上げることが予想されます。収益対市場: TECNの収益 ( 4.8% ) Austrian市場 ( 4.7% ) よりも速いペースで成長すると予測されています。高い収益成長: TECNの収益 ( 4.8% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: TECNの 自己資本利益率 は、3年後には低くなると予測されています ( 8.7 %)。成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/12 16:57終値2026/07/10 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Tecan Group AG 8 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。16 アナリスト機関Harry GillisBerenbergDelphine Le LouetBernsteinSusannah LudwigBernstein13 その他のアナリストを表示
お知らせ • May 13Tecan Group AG Reaffirms Earnings Guidance for the Year 2026Tecan Group AG reaffirmed earnings guidance for the year 2026. The company reaffirms its 2026 guidance, as most recently communicated on March 16, 2026, with sales growth in the low single-digit percentage range in local currencies.
Buy Or Sell Opportunity • Jun 05Now 23% undervaluedOver the last 90 days, the stock has risen 19% to €171. The fair value is estimated to be €222, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.5% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • May 13Tecan Group AG Reaffirms Earnings Guidance for the Year 2026Tecan Group AG reaffirmed earnings guidance for the year 2026. The company reaffirms its 2026 guidance, as most recently communicated on March 16, 2026, with sales growth in the low single-digit percentage range in local currencies.
お知らせ • Apr 16Tecan Group Ag Announces Executive ChangesTecan Group AG in its AGM meeting held on April 15, 2026, announced that shareholders elected three new members of the Board of Directors: Nina Beikert, Gitte Pugholm Aabo and Guillaume Daniellot. Matthias Gillner, who has been a member of the Board of Directors since 2023 and its Vice-Chairman, was elected as the new Chairman. He will step down as Chair of the Audit Committee but will remain a member, alongside Guillaume Daniellot and Gitte Pugholm Aabo. With the addition of the newly elected members, the Board of Directors will once again comprise seven members, ensuring an optimal balance of expertise, skills, and experience for the future. Lukas Braunschweiler, Chairman and a member of the Board since 2018, did not stand for re-election.
お知らせ • Mar 30The Tecan Group Announces the Appointment of Camila Japur as Chief Financial Officer, Effective on June 1, 2026The Tecan Group announced the appointment of Camila Japur as Chief Financial Officer, who will join the company on June 1, 2026. Camila currently serves as Group CFO of u-blox, where she has successfully led transformation initiatives, driving cost efficiency, strengthening financial processes, and enhancing capital market engagement. Prior to this, Camila spent 24 years at Ericsson, including seven years as CFO for the Enterprise Segment. Camila has an MBA from Fundação Getulio Vargas in São Paulo and a Bachelor's Degree in Economics from Universidade Mackenzie in São Paulo.
お知らせ • Mar 25Tecan Group AG Announces Member of the Board of Directors Oliver Fetzer Will Not Stand for Re-ElectionTecan Group AG announced that Oliver Fetzer, a member of the Board since 2011, has decided not to stand for re-election at the AGM to be held on April 15, 2026.
Reported Earnings • Mar 17Full year 2025 earnings released: CHF8.74 loss per share (vs CHF5.30 profit in FY 2024)Full year 2025 results: CHF8.74 loss per share (down from CHF5.30 profit in FY 2024). Revenue: CHF882.5m (down 5.5% from FY 2024). Net loss: CHF110.7m (down 264% from profit in FY 2024). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Life Sciences industry in Europe.
お知らせ • Mar 16+ 1 more updateTecan Group AG Proposes Dividend for the Full Year 2025The Board of Directors of Tecan Group AG will propose an unchanged dividend of CHF 3.00 per share at the Annual General Meeting on April 15, 2026 for the full year 2025. Half of the dividend, i.e., CHF 1.50, will again be paid out from the available capital contribution reserve and is therefore not subject to withholding tax.
Board Change • Mar 02Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Jan 28Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €173, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 18x in the Life Sciences industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €294 per share.
Board Change • Jan 13Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Dec 19Tecan Group AG to Report First Half, 2026 Results on Aug 11, 2026Tecan Group AG announced that they will report first half, 2026 results on Aug 11, 2026
お知らせ • Dec 05Tecan Group AG, Annual General Meeting, Apr 15, 2026Tecan Group AG, Annual General Meeting, Apr 15, 2026.
お知らせ • Dec 04ecan Group AG Announces Chairman of the Board of Directors Lukas Braunschweiler Will Not Stand for Re-ElectionTecan Group AG announced that Lukas Braunschweiler, Chairman of the Board of Directors and a member of the Board since 2018, will not stand for re-election.
お知らせ • Dec 02Tecan Group AG (SWX:TECN) acquired Wako Automation.Tecan Group AG (SWX:TECN) acquired Wako Automation on December 1, 2025. Tecan Group AG (SWX:TECN) completed the acquisition of Wako Automation on December 1, 2025.
お知らせ • Nov 17+ 1 more updateTecan Group AG Announces Departure of Tania Micki as Member of the Management BoardTecan Group AG announced that Tania Micki, member of the Management Board since February 2020, will be leaving the company to pursue an external opportunity. She will continue in her role through May 2026 to ensure a smooth transition. Tecan will nominate her successor in due time, leveraging the company’s succession planning process.
Board Change • Nov 05Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Christa Kreuzburg was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.